Bona fide endocannabinoids are physiological ligands of type 1 and type 2 cannabinoid receptors (CB1R and CB2R) and implicated in neurological, metabolic and cardiovascular diseases (reviewed in)12. This evidence concerns the gene CNR1 and cardiovascular disorder.